首页> 外文OA文献 >Clinical outcome of FLAG-IDA chemotherapy sequential with Flu–Bu3 conditioning regimen in patients with refractory AML: a parallel study from Shanghai Institute of Hematology and Institut Paoli-Calmettes

【2h】

Clinical outcome of FLAG-IDA chemotherapy sequential with Flu–Bu3 conditioning regimen in patients with refractory AML: a parallel study from Shanghai Institute of Hematology and Institut Paoli-Calmettes

机译：难治性AML患者Flu-Bu3调理方案顺序临床结果：上海血液学研究所的平行研究，Paoli-Updettes

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Ling Wang; Raynier Devillier; Ming Wan; Justine Decroocq; Liang Tian; Sabine Fürst; Li-Ning Wang; Norbert Vey; Xing Fan; Didier Blaise; Jiong Hu;
展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献

1. Clinical outcome of FLAG-IDA chemotherapy sequential with Flu-Bu3 conditioning regimen in patients with refractory AML: a parallel study from Shanghai Institute of Hematology and Institut Paoli-Calmettes [J] . Wang Ling, Devillier Raynier, Wan Ming, Bone marrow transplantation . 2019,第3期

机译：难治性AML患者Flu-Bu3调理方案顺序临床结果：上海血液学研究所的平行研究，Paoli-Updettes
2. Venetoclax in Combination with FLAG-IDA Chemotherapy (FLAG-V-I) for Fit, Relapsed/Refractory AML Patients: Interim Results of a Phase 1b/2 Dose Escalation and Expansion Study [J] . DiNardo Courtney D., Albitar Maher, Kadia Tapan M., Blood: The Journal of the American Society of Hematology . 2018,第NovaelaTreatmentAppr期

机译：威尼柯克斗与Flag-IDA化疗（Flag-V-I）组合配合，复发/难治性AML患者：1B / 2剂量升级和扩展研究的中期结果
3. FLAG-IDA Regimen as Bridge Therapy to Allotransplant in Refractory/Relapsed AML Patients: A Single Center Experience [J] . Delia M., Pastore D., Carluccio P., Annals of hematology . 2017,第Suppla1期

机译：Flag-Ida作为桥接治疗令人难以置力的/复发AML患者的协调疗法：单一中心经验
4. Clinical outcome of FLAG-IDA chemotherapy sequential with Flu–Bu3 conditioning regimen in patients with refractory AML: a parallel study from Shanghai Institute of Hematology and Institut Paoli-Calmettes [O] . Ling Wang, Raynier Devillier, Ming Wan, -1

机译：难治性AML患者采用FLAG-Bu3调理方案进行FLAG-IDA化疗的临床效果：上海血液学研究所和保利-卡拉迈特研究所的一项平行研究
5. Outcome of High-Risk and Refractory AML/MDS Patients Receiving a Flamsa Sequential Chemotherapy Regimen Followed by Reduced-Intensity Conditioning (RIC) and Allogeneic Hematopoeitic Stem Cell Transplantation (allo-HSCT) [O] . Detrait M., Chevallier P., Sobh M., 2012

机译：高风险和难治性AML / MDS患者接受Flamsa顺序化疗方案，随后进行低强度调节（RIC）和同种异体造血干细胞移植（allo-HSCT）的结果

Clinical outcome of FLAG-IDA chemotherapy sequential with Flu–Bu3 conditioning regimen in patients with refractory AML: a parallel study from Shanghai Institute of Hematology and Institut Paoli-Calmettes

著录项

引文网络

相似文献

相关主题

期刊订阅